ReviewDiagnostics (Basel, Switzerland)2026
A Review of U-Net Based Deep Learning Frameworks for MRI-Based Brain Tumor Segmentation.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Tumor Segmentation and Grading on MRI Using Deep Learning: A Systematic Literature Review and Benchmark-Driven Comparative Analysis.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated segmentation of brain tumors from Magnetic Resonance Imaging (MRI) images is helpful for clinical diagnosis, surgical planning, and post-treatment monitoring. In recent years, the U-Net architecture has been observed as one of the most popular solutions among deep learning models. This article presents a review of 35 studies published between 2019 and 2025 focusing on U-Net-based brain tumor segmentation. The primary focus of this review is an in-depth analysis of commonly used U-Net architectures. The transformation of original 2D and 3D models into more advanced variants is examined in detail. Results from a wide range of studies are synthesized, and standard evaluation criteria are summarized along with benchmark datasets such as the BRATS competition to validate the effectiveness of these models. Additionally, the paper overviews the recent developments in the field, determines fundamental challenges, and provides insight into future directions, including improving model efficiency and generalization, combining multimodal data, and advancing clinical applications. This review serves as a guide for researchers to examine the impact of the U-Net architecture on brain tumor segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.